Kraig Biocraft Laboratories, Inc.
For the period ended Dec 31, 2025. Filed Mar 30, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 30, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
(a)
| 1. | The financial statements listed in the “Index to Financial Statements” at page F-1 are filed as part of this report. The financial statements listed in the “Index to Financial Statements” at page F-1 are filed as part of this report. |
| 2. | Financial statement schedules are omitted because they are not applicable, or the required information is shown in the financial statements or notes thereto. |
| 3. | Exhibits included or incorporated herein: see index to Exhibits. |
(b) Exhibits
| EXHIBIT NUMBER | DESCRIPTION |
| 3.1 | Articles of Incorporation (1) |
| 3.2 | Articles of Amendment (3) |
| 3.3 | Articles of Amendment, filed with the Wyoming Secretary of State on November 15, 2013 (6) |
| 3.4 | Articles of Amendment, filed with the Wyoming Secretary of State on December 17, 2013 (7) |
| 3.5 | By-Laws (1) |
| 4.1 | Form of Warrant issued Mr. Jonathan R. Rice (14) |
| 4.2 | Description of Securities (20) |
| 4.3 | Form of Warrant dated March 25, 2021 (18) |
| 4.4 | Form of Warrant dated January 18, 2022 (19) |
| 10.1 | Employment Agreement, dated November 10, 2010, by and between Kraig Biocraft Laboratories, Inc. and Kim Thompson (8) |
| 10.2 | Addendum to the Founder’s Stock Purchase and Intellectual Property Transfer Agreement, dated December 26, 2006, and the Founder’s Stock Purchase and Intellectual Property Transfer Agreement dated April 26, 2006 (3) |
| 10.3 | Intellectual Property/Collaborative Research Agreement dated March 20, 2010, by and between Kraig Biocraft Laboratories and The University of Notre Dame du Lac. (2) |
| 10.4 | License Agreement dated October 28, 2011, between the Company and University of Notre Dame du Lac. (12) |
| 10.5 | Intellectual Property / Collaborative Research Agreement dated June 6, 2012, between the Company and University of Notre Dame du Lac. (12) |
| 10.6 | Employment Agreement, dated January 19, 2015, between the Company and Mr. Jonathan R. Rice (11) |
| 10.7 | Intellectual Property and Collaborative Research Agreements dated March 4, 2015, between the Company and University of Notre Dame du Lac. (15) |
| 10.8 | 2019 Employee Stock Option Plan (16) |
| 10.8 | Strategic Partnership Agreement (portions of the exhibit have been omitted because they are (i) not material and (ii) would likely cause competitive harm to the Registrant if publicly disclosed) (17) |
| 10.10 | Amendment (portions of the exhibit have been omitted because they are (i) not material and (ii) would likely cause competitive harm to the Registrant if publicly disclosed) (17) |
| 10.11 | Form of Registration Rights Agreement dated March 25, 2021. (18) |
| 10.12 | Form of Amended and Restated Security Agreement dated January 18, 2022 (19) |
| 10.13 | Form of Registration Rights Agreement dated January 18, 2022 (19) |
| 10.14 | Standby Equity Purchase Agreement dated as of January 21, 2025, by and between the Company and YA II PN, LTD. (23) |
| 14.1 | Code of Business Conduct and Ethics (13) |
| 19.1 | Insider Trading Policy (21) |
| 21.1 | Subsidiaries (22) |
| 31.1 | Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer. * |
| 31.2 | Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer. * |
| 32.1 | Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. + |
| 32.2 | Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. + |
| 101.INS* | Inline XBRL Instance Document |
| 101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.SCH* | Inline XBRL Taxonomy Extension Schema Document |
| 101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB* | Inline XBRL Taxonomy Extension Labels Linkbase Document |
| 101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101). |
- Filed herewith
- Furnished and not filed
(1) Incorporated by reference to our Registration Statement on Form SB-2 (Reg. No. 333-146316) filed with the SEC on September 26, 2007.
(2) Incorporated by reference to our annual report on Form 10-K for the year ended December 31, 2009, filed with the SEC on April 15, 2010.
(3) Incorporated by reference to our Registration Statement on Form S-1 (Reg. No. 333-162316) filed with the SEC on October 2, 2009.
(4) Incorporated by reference to our Current Report on Form 8-K filed with the SEC on June 29, 2011.
(5) Incorporated by reference to our Quarterly Report on Form 10-Q filed with the SEC on May 15, 2013.
(6) Incorporated by reference to our Current Report on Form 8-K filed with the SEC on November 22, 2013.
(7) Incorporated by reference to our Current Report on Form 8-K filed with the SEC on December 19, 2013.
(8) Incorporated by reference to our Registration Statement on Form S-1 (Reg. No. 333-175936) filed with the SEC on August 1, 2011.
(9) Incorporated by reference to our Registration Statement on Form S-1 (Reg. No. 333-199820) filed with the SEC on November 3, 2014.
(10) Incorporated by reference to our Amendment No. 1 to Registration Statement on Form S-1/A (Reg. No. 333-199820) filed with the SEC on January 7, 2015.
(11) Incorporated by reference to our Current Report on Form 8-K filed with the SEC on January 21, 2015.
(12) Incorporated by reference to our Amendment No. 2 to Registration Statement on Form S-1/A (Reg. No. 333-199820) filed with the SEC on January 30, 2015.
(13) Incorporated by reference to Exhibit 14.1 to our Annual Report on Form 10-KSB for the year ended December 31, 2007, filed with the SEC on March 26, 2008.
(14) Incorporated by reference to Exhibit 4.1 to the Annual Report on Form 10-K filed on March 31, 2015
(15) Incorporated by reference to Exhibit 10.15 to the Annual Report on Form 10-K filed on March 31, 2015
(16) Incorporated by reference to Exhibit 10.16 to the Annual Report on Form 10-K filed on March 27, 2020
(17) Incorporated by reference to our Current Report on Form 8-K filed with the SEC on January 26, 2021.
(18) Incorporated by reference to our Current Report on Form 8-K filed with the SEC on March 26, 2021.
(19) Incorporated by reference to our Current Report on Form 8-K filed with the SEC on January 20, 2022.
(20) Incorporated by reference to Exhibit 4.2 to the Annual Report on Form 10-K filed on April 1, 2024.
(21) Incorporated by reference to Exhibit 14.1 to the Annual Report on Form 10-K filed on April 1, 2024.
(22) Incorporated by reference to Exhibit 21.1 to the Annual Report on Form 10-K filed on April 1, 2024.
(23) Incorporated by reference to Exhibit 10.1 our Current Report on Form 8-K filed with the SEC on January 21, 2025.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.